Willis Towers Watson PLC (WTW) is a leading global advisory, broking, and solutions firm, dedicated to delivering innovative risk management, insurance, and consulting services across more than 140 countries. With a strong emphasis on advanced data analytics and technology, WTW provides tailored solutions to address critical issues in health, retirement, and talent management for a diverse client base, including multinational corporations and small businesses. The firm’s commitment to driving sustainable growth and enhancing client engagement positions it as a trusted partner in navigating complex market dynamics, further solidifying its status as an industry leader.
| Revenue (TTM) | $10.27B |
| Gross Profit (TTM) | $4.38B |
| EBITDA | $2.88B |
| Operating Margin | 20.00% |
| Return on Equity | 20.20% |
| Return on Assets | 5.35% |
| Revenue/Share (TTM) | $109.01 |
| Book Value | $84.08 |
| Price-to-Book | 4.01 |
| Price-to-Sales (TTM) | 3.02 |
| EV/Revenue | 3.528 |
| EV/EBITDA | 13.17 |
| Quarterly Earnings Growth (YoY) | 4.40% |
| Quarterly Revenue Growth (YoY) | 7.50% |
| Shares Outstanding | $92.22M |
| Float | $91.76M |
| % Insiders | 0.27% |
| % Institutions | 103.02% |
Volatility is currently contracting
NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ: WTW), today announced the appointment of Robert Staeheli as Head of Defense and Security, North America. Based in Washington, D.C., Staeheli will lead the company's strategy and growth for defense and security clients across the U.S. and Canada, while continuing to serve as Metro D.C. Market Leader.
LONDON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Geopolitical tensions are the top economic risk facing the life sciences industry, according to the latest report from Willis, a WTW business, (NASDAQ:WTW); Managing the new economic risks in life sciences. Based on insights from senior executives and risk professionals across North America, Europe and Asia, the research highlights growing concern that geopolitical rivalry, trade policy and government intervention are increasingly shaping where products are developed, manufactured and sold.
Willis Towers Watson Public NASDAQ: WTW reported third-quarter organic revenue growth of 4%, adjusted operating margin expansion of 150 basis points and adjusted diluted earnings per share growth of 18%, Chief Executive Officer Carl Hess said on the company's earnings call.
Willis Towers Watson Public Limited Company (WTW) Q3 2026 Earnings Call Transcript
Willis Towers Watson beats Q3 earnings estimates as organic growth, expanding margins and strong cash flow support its 2026 outlook and AI-driven savings plan.
The headline numbers for Willis Towers Watson (WTW) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Willis Towers Watson (WTW) came out with quarterly earnings of $3.63 per share, beating the Zacks Consensus Estimate of $3.6 per share. This compares to earnings of $3.07 per share a year ago.
Employers are quietly reconsidering who foots the bill for GLP-1 weight-loss drugs, and the fallout hits Eli Lilly and Novo Nordisk very differently heading into earnings week.
Willis Towers Watson launches Via Retirement to expand its wealth business, tapping growing demand for retirement-income solutions and potential advisory and annuity revenue.
Here, we look at three insurance stocks, RYAN, AJG and WTW, set to report third-quarter earnings on Oct. 29.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WTW and any ticker you trade — then tracks every position and per-strategy win rate.
